The PI3K–PTEN–AKT–mTOR pathway, important in the control of cell growth, tumorigenesis, and cell invasion, has been shown to be abnormally activated in several cancer types, including NSCLC (102, 103). The gene discussed is PIK3CA; the disease is non-small cell lung carcinoma.